Publication Beamlines Strategic Pillar
ハン・リー; ドロシア・コミノス; ジエ・ジャーン; アラ・プリッツカー; マシュー・ディヴィソン et al. (2024). Antibodies against bradykinin B1 receptor ligand. Patent Number: JP7411609B2.
庫丹達拉姆 皮拉瑞斯提; 艾瑞克 鮑德溫; 戈登 包爾斯; 羅沙 卡多索; 里卡多 阿塔爾 et al. (2024). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: TW202406935A.
琼·塞奥尼苏亚雷斯; 茱蒂特·艾尼多弗古艾拉; 约翰·弗兰松; 让-菲利普·朱利安; 斯威萨·拉曼 et al. (2024). Anti-LIF antibodies and uses thereof. Patent Number: CN118652335A. CMCF-ID Health
琼·塞奥尼苏亚雷斯; 茱蒂特·艾尼多弗古艾拉; 约翰·弗兰松; 让-菲利普·朱利安; 斯威萨·拉曼 et al. (2024). Anti-LIF antibodies and uses thereof. Patent Number: CN111868086B. CMCF-ID Health
(2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T.
(2023). Antibodies to tigit. Patent Number: IL298111A.
(2023). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND USES THEREOF. Patent Number: CY2023007I2.
(2023). teclistamab. Patent Number: NL301219I2.
(2023). ANTI-BCMA ANTIBODIES, BCMA AND CD3-BINDING BISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF. Patent Number: FR23C1011I1.
(2023). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL257468B2.
(2023). Novel tnf structure for use in therapy. Patent Number: PT3311168T.
수아레즈 조안 세오아네; 폴게이라 주딧 아니도; 조 프란슨; 진-필리프 줄리엔; 스웨타 라만 et al. (2023). Antibodies to LIF and their uses. Patent Number: KR102599557B1. CMCF-ID Health
제임스 필립 오코넬; 존 로버트 포터; 알라스테어 로손; 다니엘 존 라이트우드; 레베카 제인 우튼 et al. (2023). antibody. Patent Number: KR102599907B1.
켈시 시빅 고티에; 니겔 펠험 클린턴 워커; 샤오닝 자오; 존 리핀코트 (2023). Antibodies to TIGIT. Patent Number: KR20230019152A.
フィリップ オコンネル、ジェイムズ; ロバート ポーター、ジョン; ローソン、アラステア; クロープリアン、ボリス; エドワード ラペッキ、スティーブン et al. (2023). Novel TNFα structures for use in therapy. Patent Number: JP7336178B2.